ClinicalTrials.govpublic full text
A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
melanoma, cancer, advanced cancer, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801205
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.